German China
Cancer patients receiving anthracycline chemotherapy have more than twice the risk of developing heart failure compared to their peers without cancer. (Source: Pixabay)
Cardiology

Heart Failure Could be Prevented for Cancer Patients

The EU-funded Resilience project aims to prevent heart failure in cancer patients who need anthracyclines. The project is testing a promising preventive treatment called remote ischaemic conditioning in lymphoma patients at risk for anthracycline cardiotoxicity. If the results are positive, heart failure could be significantly reduced in cancer survivors.

Read on